Prevail Innovative Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Buy
6,806
+295
+5% +$68.7K 0.28% 109
2025
Q4
$1.35M Buy
6,511
+533
+9% +$105K 0.24% 135
2025
Q3
$1.11M Buy
5,978
+1,589
+36% +$272K 0.22% 145
2025
Q2
$670K Sell
4,389
-151
-3% -$23.2K 0.15% 157
2025
Q1
$753K Buy
4,540
+3,092
+214% +$484K 0.2% 124
2024
Q4
$209K Buy
+1,448
New +$224K 0.06% 154

Other funds holding JNJ

Prevail Innovative Wealth Advisors's JNJ Position: Q1 2026 in Review

Prevail Innovative Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 4.5% in Q1 2026, buying an estimated $68.7K and bringing the position to 6,806 shares worth $1.66M. The position accounts for 0.28% of the portfolio, ranked #109.

Prevail Innovative Wealth Advisors first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Prevail Innovative Wealth Advisors held 6,806 shares of Johnson & Johnson worth $1.66M as of Q1 2026.
  • Prevail Innovative Wealth Advisors bought 295 Johnson & Johnson shares in Q1 2026, an estimated $68.7K.
  • Johnson & Johnson made up 0.28% of Prevail Innovative Wealth Advisors's portfolio in Q1 2026, its #109 holding.
  • Prevail Innovative Wealth Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Prevail Innovative Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.